[Effect of adrenergic alpha and beta receptor blockaders and the stimulation and blockade of muscarinic receptors in insulinemia and glycemia in healthy persons and patients with diabetes].
D000317:Adrenergic alpha-Antagonists; D000328:Adult; D001285:Atropine; D001786:Blood Glucose / Q000032:analysis*; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000097:blood*; D004347:Drug Interactions; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood*; D007329:Insulin Antagonists; D008297:Male; D008875:Middle Aged; D010646:Phentolamine; D011433:Propranolol; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects*; D013268:Stimulation, Chemical
D000317:Adrenergic alpha-Antagonists; D001786:Blood Glucose; D007328:Insulin; D007329:Insulin Antagonists; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D001285:Atropine; D011433:Propranolol; D010646:Phentolamine
Wpływ blokowania receptorów adrenergicznych typu alfa i beta oraz stymulacji i blokowania cholinergicznych receptorów typu muskarynowego na insulinemie i glikemie u ludzi zdrowych i chorych na cukrzyce.